A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.
Browsing Category


One Antibody Trial Is Halted, While Others Continue

An ongoing trial of the antibody bamlanivimab—administered with remdesivir, an antiviral medication—on hospitalized COVID-19 patients has been halted by bamlanivimab’s manufacturer Eli Lilly. The decision was made to stop the trial after…

COVID-19 Death Rates Drop Among Hospitalized Patients

Two peer-reviewed studies demonstrate a decrease in deaths among hospitalized patients with COVID-19 across the board, including older adults and those with comorbidities. One study looked at 5,000 hospitalized COVID-19 patients in New York…

Remdesivir Approved as First COVID-19 Treatment

The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (brand name Veklury, Gilead Sciences) for treating patients hospitalized with COVID-19. This is the first treatment for COVID-19 to receive FDA approval.…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy